It was revealed that the co-existence of NAFLD and chronic hepatitis B is common among patients that may synergistically exacerbate liver fibrosis and hepatocellular carcinoma.[62] It was reported that NAFLD-induced lipid accumulation may accelerate tumorigenesis through activation of PI3K. Here, PIK3CA is linked to metabolic dysfunction-associated steatotic liver disease.